GlassScriptPhysician profile
Jennifer Martin
NPI 1083642045
$3,173.01
in general payments reported to CMS, 2019-2025
14 companies · $350 in 2025
The $350 reported for 2025 was more than what a typical Physical Medicine & Rehabilitation provider received nationally (typical 2025 total: $138).
See the full distribution for Physical Medicine & Rehabilitation
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $575 · 2020: $32.50 · 2021: $59.83 · 2022: $56.43 · 2023: $112 · 2024: $1,987 · 2025: $350.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,482 · Food and Beverage: $967.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,482.10 |
| Food and Beverage | $966.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,212.38 | 2019-2025 | Proclaim, Octrode |
| Curonix LLC | $870.33 | 2024-2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Medtronic, INC. | $307.78 | 2023-2025 | Inceptiv, Vanta Adaptivestim, Intellis Adaptivestim |
| Pfizer INC. | $255.01 | 2019 | |
| Peerless Surgical INC. | $118.16 | 2019 | |
| Abbvie INC. | $107.30 | 2021-2025 | |
| Boston Scientific Corporation | $94.37 | 2019 | |
| Si-Bone, INC. | $61.56 | 2019-2020 | |
| Janssen Biotech, INC. | $44.17 | 2023-2025 | Tremfya |
| Ermi LLC | $28.01 | 2019 | |
| Horizon Therapeutics Plc | $26.54 | 2019-2022 | |
| Amgen INC. | $19.58 | 2021 | |
| Sanofi-Aventis U.S. LLC | $15.93 | 2020 | |
| Novo Nordisk INC | $11.89 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer Martin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.